‘Mitotherapy’ for heart failure

Thumbnail Image
Identifiers
URI: http://hdl.handle.net/11268/5149
DOI: 10.1016/j.molmed.2016.02.007

Publication date

2016

Authors

Sanchís-Gomar, Fabián
Lippi, Giuseppe

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar
7

Research Projects

Organizational Units

Journal Issue

Abstract

Abnormalities in mitochondrial dynamics along with those for the molecular mediators involved are presently being viewed with increased interest in the field of cardiovascular disease. Recent research highlights OPA1, a dynamin-like GTPase mediating mitochondrial fusion, as well as the 'mitoproteases' OMA1 and YME1L, as potential therapeutic targets against heart failure.

Description

UNESCO Subjects

Enfermedad cardiovascular
Envejecimiento

Keywords

Bibliographic reference

Sanchis-Gomar, F., Lippi, G., & Lucia, A. (2016). ‘Mitotherapy’ for heart failure. Trends in molecular medicine, 22(4), 267-269.

Type of document

journal article

Collections

Área de Actividad Física y Salud